Characteristic | Treatment success | Sputum liquid culture conversion within 2 months | ||
---|---|---|---|---|
aHR (95% CI) | P-value | aHR (95% CI) | P-value | |
Age, years | 0.99 (0.98–1.00) | 0.166 | 1.00 (0.99–1.01) | 0.597 |
Sex, male | 0.99 (0.69–1.42) | 0.951 | 1.30 (0.86–1.97) | 0.210 |
Chronic liver disease | 0.80 (0.42–1.50) | 0.478 | 0.77 (0.38–1.58) | 0.478 |
Charlson comorbidity index score | 0.89 (0.65–1.22) | 0.473 | 0.96 (0.67–1.38) | 0.827 |
Cavitation evident in initial chest X-ray | 0.71 (0.50–1.03) | 0.069 | 0.81 (0.54–1.22) | 0.310 |
Smear-positivity of initial sputum specimen | 0.60 (0.43–0.83) | 0.002 | 0.52 (0.35–0.78) | 0.001 |
Drug-induced hepatotoxicity | 0.97 (0.57–1.65) | 0.915 | 0.89 (0.48–1.62) | 0.692 |